Skip to main content

Table 2 Correlates associated with CIN positivity by demographic and clinical characteristics

From: The role of co-infections and hormonal contraceptives in cervical intraepithelial neoplasia prevalence among women referred to a tertiary hospital in Western Kenya

Characteristic

Univariate

Multivariable

N

Event N

OR1

95% CI1

p-value

OR1

95% CI1

p-value

Age category

189

95

  

0.180

   

≤ 30 years

  

ref.

—

 

ref.

—

 

> 30 years

  

1.81

0.76, 4.54

 

1.27

0.41, 4.21

0.700

Marital status

189

95

  

< 0.001

   

Married

  

ref.

—

 

ref.

—

 

Single

  

0.80

0.10–4.96

 

2.32

0.24, 19.6

0.400

Widow

  

11.4

3.18–73.2

 

11.9

2.53, 90.1

0.005

parity

189

95

  

0.460

   

≤ 4 children

  

ref.

—

    

> 4 children

  

1.27

0.68–2.38

    

Contraceptives types

189

95

  

0.017

   

None

  

ref.

—

 

ref.

—

 

Hormonal-IUD

  

1.43

0.28–10.9

 

1.85

0.28–16.4

0.500

Implant Jadele/Norplant

  

0.40

0.15–0.96

 

1.18

0.37–3.86

0.800

injectable /Depo-provera

  

0.28

0.11–0.67

 

0.81

0.25–2.63

0.700

Oral pill

  

0.20

0.02–1.24

 

0.72

0.08–5.47

0.800

Contraceptive duration

189

95

  

0.700

   

≤ 20

  

ref.

—

    

> 20 years

  

1.16

0.52–2.63

    

HIV status

189

95

  

< 0.001

   

negative

  

ref.

—

 

ref.

—

 

positive

  

2.79

1.56–5.10

 

2.43

1.25, 4.79

0.009

HSV2

189

95

  

0.024

   

Negative

  

ref.

—

 

ref.

—

 

Positive

  

2.41

1.12–5.46

 

2.70

1.15, 6.69

0.026

Chlamydia

189

95

  

< 0.001

   

Negative

  

ref.

—

 

ref.

—

 

Positive

  

3.83

1.84–8.51

 

3.63

1.61, 8.65

0.002

  1. Regression analysis. 1OR = Odds Ratio; CI = Confidence Interval; ref = reference; HSV-2, Herpes simplex virus-2; HPV, Human papilloma virus